Company News
Paolo Paoletti joins PsiOxus Therapeutics at Chairman
Paolo Paoletti joins PsiOxus Therapeutics at Chairman
Former President of GSK Oncology adds depth of knowledge of cancer R&D
Merck announces new biopharma heads for North America and China
Merck announces new biopharma heads for North America and China
Gary Zieziula and Marc Horn to head biopharma business in North America and China, respectively
Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis
Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis
Will build sales in the Boston Biotech community
Avacta hires Philippe Cotrel as Chief Commercial Officer
Avacta hires Philippe Cotrel as Chief Commercial Officer
Joins the UK firm from Abcam
Averica Discovery appoints Cynthia Berger as Vice President of Operations
Averica Discovery appoints Cynthia Berger as Vice President of Operations
Will contribute broadly to the firm's growth and development
Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult
Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult
The new Medicines Technologies Catapult at Alderley Park, Cheshire, UK, will support industry in developing new technologies primarily for the preclinical evaluation of medicines
Recipharm appoints new Key Account Director for Europe
Recipharm appoints new Key Account Director for Europe
Anke Mollowitz is responsible for coordinating customer management and commercial aspects
Remi Palmantier becomes Chief Scientific Officer at Genticel
Remi Palmantier becomes Chief Scientific Officer at Genticel
Will accelerate the discovery, development and integration of specific immunotherapies
Chief Medical Officer Birgitte Volck to leave Sobi
Chief Medical Officer Birgitte Volck to leave Sobi
To join GlaxoSmithKline as Head of R&D Rare Diseases
Ergomed makes changes to Board of Directors
Ergomed makes changes to Board of Directors
Neil Clark becomes CEO of PrimeVigilance, while Stephen Stamp is appointed as Chief Financial Officer of Ergomed
Crown Bioscience hires Global Scientific Director for Translational Oncology
Crown Bioscience hires Global Scientific Director for Translational Oncology
Eric Murphy has focused on translational and drug discovery research for more than two decades
ClinTec International expands executive leadership team
ClinTec International expands executive leadership team
Hires Dr Harley Simon as Chief Medical Officer & Executive Vice President Client Relations
West appoints VP, Corporate Development, Strategy and Investor Relations
West appoints VP, Corporate Development, Strategy and Investor Relations
Quintin Lai joins the US firm from Sigma Aldrich
Chalcroft announces new structure following significant growth
Chalcroft announces new structure following significant growth
Gives new roles to management and makes some promotions
Frank Mathias to become CEO of Rentschler Biotechnologie
Frank Mathias to become CEO of Rentschler Biotechnologie
Nikolaus Rentschler joins supervisory board to concentrate on further expansion of the Rentschler Group
Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France
Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France
Yves Buelens, who has been plant manager since 2014, gains a promotion
Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer
Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer
He beings extensive experience to the newly created role
HUYA Bioscience International expands senior management team
HUYA Bioscience International expands senior management team
Recruits Dmitri Kharkevitch as Vice President for Clinical Development
Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer
Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer
Brings two decades of experience in quality, manufacturing, product safety and regulatory affairs to the firm
Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing
Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing
Will lead business activity concerning SMARTag bioconjugation technology
Lonza announces change to Executive Committee
Lonza announces change to Executive Committee
Sven Abend, Chief Strategy Officer and member of the Executive Committee, takes responsibility for Specialty Ingredients from Beat In-Albon
Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development
Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development
New role strengthens Immune's ability to advance portfolio through strategic partnering
Joseph P. Hagan becomes Chief Operating Officer at Regulus
Joseph P. Hagan becomes Chief Operating Officer at Regulus
He brings nearly 15 years of experience to the La Jolla, CA, US-based firm
Belgian biotech Promethera makes two senior appointments
Belgian biotech Promethera makes two senior appointments
Dr Jürgen Beck is hired as VP Clinical and Medical Affairs, with Patrick Stragier as VP Operations